AIIMS Mangalagiri has reached a significant milestone by conferring degrees on 49 MBBS graduates, along with five MD/MS postgraduate students and four Post-Doctoral Certificate Course students. This achievement highlights the institution’s growth since the MBBS course began in 2018, which started with an initial intake of 50 students and has now expanded to 748 students, with an annual intake of 125.

The hospital has also completed an impressive 31 lakh outpatient department (OPD) consultations, showcasing its vital role in the healthcare landscape of Andhra Pradesh. Currently, AIIMS Mangalagiri sees a daily patient footfall of around 3,500 to 4,000, reflecting the increasing demand for its services.

In a groundbreaking development, AIIMS Mangalagiri has installed a Nucleic Acid Amplification Testing (NAAT) system, the first of its kind among all AIIMS in South India. This advanced system, which cost approximately ₹1.73 crore, enhances diagnostic capabilities by detecting viral RNA/DNA with high sensitivity, allowing for early identification of infections such as HIV, Hepatitis B, and Hepatitis C.

Union Minister Anupriya Patel emphasized the government’s commitment to the medical sector, stating, “The Union government under the leadership of Prime Minister Narendra Modi is giving utmost priority to the medical sector.” This statement underscores the ongoing efforts to improve healthcare access and quality for the population.

Ahanthem Singh, a representative from AIIMS Mangalagiri, noted that the NAAT system significantly enhances safety by reducing the diagnostic window period. This advancement is expected to improve patient outcomes and streamline the testing process.

As AIIMS Mangalagiri continues to evolve, observers anticipate further developments in medical education and patient care. The institution’s focus on innovation and quality healthcare is likely to set a benchmark for other medical colleges in the region.

With these advancements, AIIMS Mangalagiri is poised to play a crucial role in addressing the healthcare needs of the community, ensuring that quality medical education and services are accessible to all.

The future looks promising for AIIMS Mangalagiri as it continues to expand its capabilities and enhance its offerings to students and patients alike.

The post AIIMS Mangalagiri Achieves Milestone with Degree Conferral appeared first on berightnews.

The recent study on acute respiratory distress syndrome (ARDS) subtypes has unveiled critical findings that could reshape patient management strategies. Notably, the research indicates that these subtypes can be rapidly identified at the bedside, a development that may significantly impact treatment outcomes.

In this study, patients were classified into two distinct subtypes: hyperinflammatory and hypoinflammatory. Alarmingly, 18% of the patients fell into the hyperinflammatory category, which is associated with a staggering 60-day mortality rate of 51%. In contrast, the hypoinflammatory group exhibited a lower mortality rate of 28%.

The hyperinflammatory subtype’s increased mortality risk underscores the urgent need for targeted interventions. This study provides the first prospective evidence that subphenotypes can be reliably identified in real time, paving the way for a shift toward precision medicine in managing ARDS.

Previous research had primarily relied on retrospective analyses to identify these subtypes, making this new approach a significant advancement in clinical practice. The findings support a more tailored treatment strategy, potentially improving survival rates for patients suffering from ARDS.

As healthcare professionals begin to adopt these findings, the implications for patient care could be profound. The ability to quickly identify and classify patients may lead to more effective and personalized treatment plans, ultimately saving lives.

However, while the study’s results are promising, details remain unconfirmed regarding the broader applicability of these findings across diverse patient populations. Further research is expected to clarify these uncertainties and refine treatment protocols.

In summary, the urgent insights from this study highlight the critical need for immediate action in the management of acute respiratory distress syndrome. With the potential for improved patient outcomes through precision medicine, the medical community must prioritize these findings in clinical settings.

The post Test: Urgent Findings on Acute Respiratory Distress Syndrome Subtypes: Results appeared first on berightnews.

April 2, 2026, marks World Autism Awareness Day, a significant occasion dedicated to raising awareness about autism and advocating for improved support services for individuals diagnosed with this lifelong neurodevelopmental condition. This year, the focus is on the urgent need for timely access to quality healthcare and support, as statistics reveal that 1 in 127 people globally is diagnosed with autism.

As awareness grows, the World Health Organization (WHO) emphasizes the importance of early identification, inclusive education, and nurturing care to enhance the health and well-being of autistic individuals. Despite these efforts, access to necessary services remains limited, highlighting a critical gap in support for those affected by autism.

In a broader context, the WHO is set to launch a caregiver well-being training program for children with developmental delays on April 27, 2026. This initiative aims to equip caregivers with the tools they need to provide effective support, reflecting a growing recognition of the challenges faced by families of autistic individuals.

Public discourse around autism has intensified, with various organizations advocating for neuroinclusive environments across different sectors. The WHO’s call for policies that promote such environments underscores the need for systemic change to support autistic individuals and their families.

However, the ongoing challenges are evident. Access to timely and quality healthcare remains a pressing issue, with many families struggling to navigate the complexities of support services. The need for comprehensive reforms is critical to ensure that all individuals with autism receive the care they deserve.

Reactions to World Autism Awareness Day have been mixed, with advocates calling for more robust action from governments and institutions. The WHO’s upcoming webinar on April 27 is expected to draw significant attention, as it marks a step towards addressing caregiver needs and enhancing support for autistic individuals.

As the world observes this important day, the focus remains on fostering understanding and acceptance of autism. The journey towards a more inclusive society continues, with the hope that increased awareness will lead to tangible improvements in the lives of those affected.

Details remain unconfirmed regarding the full impact of these initiatives, but the commitment to raising awareness and improving support for autism is clear.

The post 2 april: World Autism Awareness Day: April 2, 2026 appeared first on berightnews.

What actions is the National Medical Commission (NMC) taking to improve medical education in India? The NMC has launched an online feedback system for undergraduate medical students, allowing them to anonymously register complaints and evaluate their colleges’ infrastructure and faculty.

The newly introduced ‘Student Feedback Form’ seeks insights on various aspects of medical colleges and the overall educational experience. According to the NMC, “The feedback aims to gather valuable anonymous feedback on various aspects of your medical college and medical education experience.” This initiative is part of a broader effort to enhance academic quality and institutional accountability.

In addition to the feedback system, the NMC has issued warnings to students regarding admissions to foreign medical institutes in Uzbekistan that do not comply with the Foreign Medical Graduate Licentiate (FMGL) regulations. These regulations mandate a minimum of 54 months of education at a single institution and a 12-month internship at the same foreign university.

Furthermore, the NMC has identified 60 medical colleges that are failing to pay stipends to their interns, including 27 private institutions. This issue has been under scrutiny by the Supreme Court, which has been hearing cases related to unpaid stipends for MBBS interns since 2022.

The NMC has taken decisive action by imposing a penalty of Rs 1 crore on seven colleges for not providing stipend payment information. The Chief Justice remarked, “Not paying stipend to young doctors putting in 16-20 hours per day was like the practice of bonded labour,” highlighting the severity of the situation.

As of now, some MBBS interns receive a monthly stipend of Rs 2,000, but many others are left without compensation. The ongoing issue of unpaid stipends for MBBS interns has been a concern since January 25, 2019, and the Supreme Court has expressed frustration over the lack of action against erring institutions, stating, “We are forced to make this observation as no action seems to have been taken against erring institutions.”

While the NMC’s initiatives aim to enhance the quality of medical education and ensure fair treatment for interns, the effectiveness of these measures remains to be seen. Details remain unconfirmed regarding the implementation timeline for the feedback system and the resolution of stipend issues.

The post Nmc: National Medical Commission () Implements New Feedback System and Addresses Stipend Issues appeared first on berightnews.

The Kerala government has reportedly submitted multiple proposals over the years for establishing an AIIMS, a move aimed at addressing the state’s pressing healthcare needs. Despite these efforts, the Union government has yet to approve the proposal, leaving many in the state concerned about the future of healthcare infrastructure.

In 2025, the Kerala government identified land in Kinalur, Kozhikode, for the proposed AIIMS project. However, the Centre has not provided a timeline for when the approval might come, leading to frustration among local leaders and citizens alike.

Union Minister of State for Health and Family Welfare Prataprao Jadhav confirmed, “The proposal for establishing AIIMS in Kerala has not been approved,” highlighting the ongoing uncertainty surrounding the project.

The demand for an AIIMS in Kerala has become a political issue ahead of the state Assembly elections, with Congress MPs Kodikunnil Suresh and Adoor Prakash vocalizing their concerns regarding the lack of progress. They argue that the absence of such a facility is detrimental to the state’s healthcare system.

In 2016, several potential locations for AIIMS in Kerala were identified and proposed, but the journey toward realization has been fraught with delays. In 2019, the Union Health Ministry sought ‘in-principle’ approval from the Finance Ministry, yet no further steps have been taken since then.

Observers note that the absence of an AIIMS in Kerala is not just a matter of healthcare but also a significant political issue, especially as the state prepares for elections. The demand for improved healthcare services is intensifying, and the lack of an AIIMS is seen as a failure to meet these needs.

Details remain unconfirmed regarding the reasons for the delay in approval of the AIIMS proposal, as well as the timeline for its implementation. The Kerala government continues to advocate for the establishment of this critical healthcare facility, emphasizing its importance for the state’s residents.

As the political landscape heats up, the pressure on the Union government to act on the AIIMS proposal is likely to increase, with many watching closely for any developments.

The post AIIMS Proposal in Kerala Faces Continued Delays appeared first on berightnews.

The Kerala government has reportedly submitted multiple proposals over the years for establishing an AIIMS. Despite these efforts, the Union government has not approved the proposal, leaving the state’s healthcare needs unaddressed.

In 2025, the Kerala government identified land in Kinalur, Kozhikode, for the proposed AIIMS project. However, the Centre has not provided a timeline for the approval of this critical healthcare initiative.

Union Minister of State for Health and Family Welfare Prataprao Jadhav confirmed, “The proposal for establishing AIIMS in Kerala has not been approved.” This statement underscores the ongoing challenges faced by the state in securing necessary healthcare infrastructure.

The absence of an AIIMS in Kerala has become a political issue ahead of the state Assembly elections, with Congress MPs Kodikunnil Suresh and Adoor Prakash vocalizing their concerns. They argue that the demand for an AIIMS is directly linked to the state’s pressing healthcare needs.

In 2016, several potential locations for AIIMS in Kerala were identified and proposed, yet progress has stalled. By 2019, the Union Health Ministry sought ‘in-principle’ approval from the Finance Ministry, but no further developments have been reported.

Details remain unconfirmed regarding the reasons for the delay in approval of the AIIMS proposal. Observers are concerned that the lack of action could impact the healthcare landscape in Kerala significantly.

The political ramifications of this issue are palpable, as the demand for an AIIMS continues to resonate with the electorate. As the state approaches elections, the focus on healthcare infrastructure is likely to intensify.

With the Centre’s silence on the approval timeline, the future of the AIIMS project in Kerala remains uncertain. The Kerala government is expected to continue advocating for the establishment of this vital institution.

As discussions unfold, the healthcare needs of the state remain a priority, with many hoping for a resolution that addresses the longstanding demand for an AIIMS.

The situation is evolving, and stakeholders are closely monitoring developments as the political landscape shifts in the lead-up to the elections.

The post AIIMS Proposal in Kerala Remains Unapproved Amid Political Tensions appeared first on berightnews.

Sun Pharmaceutical Industries Limited, a leader in the pharmaceutical industry, is dedicated to advancing patient care in areas such as psoriasis, alopecia areata, and acne. At the 2026 AAD Annual Meeting held in Denver, Colorado, Sun Pharma presented 14 abstracts, highlighting its commitment to dermatology and immunology.

Among the key developments, ILUMYA, which targets moderate-to-severe plaque psoriasis and nail psoriasis, continues to show promise in improving patient outcomes. Additionally, LEQSELVI is being utilized for the treatment of severe alopecia areata, while WINLEVI is indicated for acne vulgaris and is often used in combination therapies.

However, not all news was positive; the Phase II FLASH study for Fibromun did not meet its primary endpoint for progression-free survival (PFS). This outcome raises questions about the future direction of this treatment.

On a more encouraging note, Nidlegy achieved complete pathological responses in 52.6% of patients in the Phase II ‘Duncan’ study, demonstrating significant efficacy. Furthermore, the GLIOSTELLA study in late-line glioblastoma has completed enrollment in the U.S., marking a critical step forward in cancer research.

Following the withdrawal of a prior Marketing Authorization Application in 2025, Sun Pharma is preparing a new submission for Nidlegy, reflecting its ongoing commitment to bringing innovative therapies to market.

Dr. Ahmad Naim commented on the presentations, stating, “The data we are presenting at AAD underscore our commitment to advancing dermatology and immunology through meaningful science – spanning not only clinical efficacy and safety, but also how these therapies perform over time and in real-world practice.” This statement reinforces the company’s focus on long-term patient care.

As the industry watches closely, observers anticipate further developments from Sun Pharma, particularly regarding the outcomes of ongoing studies and the potential impact of new submissions on the market.

Details remain unconfirmed regarding the future of Fibromun, but the company’s proactive approach suggests a determination to refine its strategies and improve patient outcomes across its product range.

The post Sun Pharma Advances Dermatology Research at AAD Annual Meeting appeared first on berightnews.

A Chennai-based firm, Subbarow Apparels, has made a significant donation of Rs 1 crore to the Tirumala Tirupati Devasthanam (TTD) for its Sri Balaji Arogya Varaprasadini scheme. This contribution aims to enhance medical facilities and acquire advanced equipment for underprivileged patients at the Sri Venkateswara Institute of Medical Sciences (SVIMS).

The donation cheque was handed over to TTD Additional Executive Officer Ch Venkaiah Chowdary, marking a pivotal moment in the ongoing efforts to provide top-quality medical services.

However, this generous act has been overshadowed by controversy surrounding TTD Chairman B.R. Naidu. Bhumana Karunakar Reddy, a prominent political figure, has publicly criticized Naidu’s conduct, labeling it as damaging to TTD’s reputation. Reddy has called for Naidu’s immediate removal, citing accusations of misusing VIP darshan privileges for political gain.

Reddy stated, “B.R. Naidu must be immediately removed for his ‘indecent and disgraceful actions.'” He further accused former Chief Minister Chandrababu Naidu of falsely claiming credit for projects while sidelining officials who contributed to their success.

The backdrop of this controversy includes the establishment of the FSSAI technology lab during the Y.S. Jagan Mohan Reddy government, which has been a point of contention in the ongoing political landscape.

As TTD continues to extend its role beyond spiritual services to support education, healthcare, and social welfare programs, the implications of this donation and the surrounding controversies are significant.

Details remain unconfirmed regarding the potential impact of these criticisms on B.R. Naidu’s position and TTD’s future initiatives.

With the Jubilee Hills Society elections approaching on April 5, the political dynamics surrounding TTD and its leadership are expected to intensify.

The intersection of philanthropy and politics in this case highlights the urgent need for transparency and integrity within TTD’s leadership.

The post Ttd: Significant Donation Sparks Controversy in Tirupati appeared first on berightnews.

As the global burden of kidney disease rises, driven by diabetes, hypertension, and environmental pressures, Dina Abdellatif states, “World Kidney Day 2026 is a powerful call to action.” This year marks the 20th anniversary of World Kidney Day, which was officially recognized by the World Health Organization (WHO) in 2025.

Chronic kidney disease (CKD) is growing at an alarming rate of around 30% annually, according to Saurabh Arora. The increasing prevalence of CKD poses significant challenges, as many cases remain asymptomatic until later stages, making early screening crucial.

The financial burden of CKD treatment is substantial, with a median annual cost exceeding ₹2 lakh for patients. This highlights the importance of preventive measures and early detection to mitigate both health and economic impacts.

The theme for World Kidney Day 2026 is “Kidney Health For All: Caring for People, Protecting the Planet,” emphasizing the connection between kidney health and planetary health. This campaign seeks to raise awareness about the environmental factors that exacerbate kidney disease.

Experts like Li-Li Hsiao stress, “Our mission is clear: raise awareness, promote early detection, and prioritize prevention on World Kidney Day and beyond.” Regular health check-ups, particularly for individuals with metabolic conditions such as diabetes, are essential. Saurabh Arora recommends that these check-ups occur at least twice a year.

Annual kidney screenings and digital health tracking are increasingly being integrated into health plans by insurers, reflecting a growing recognition of the need for proactive health management. This shift is vital as kidney disease ranks among the top ten causes of death from noncommunicable diseases.

As the campaign unfolds, it is expected to galvanize public and private sectors to prioritize kidney health initiatives. The focus on early detection and management of risk factors could significantly alter the trajectory of CKD prevalence.

With environmental threats also increasing the risk and progression of kidney disease, the call for action on World Kidney Day 2026 is more urgent than ever. Stakeholders are encouraged to engage in discussions and initiatives that promote kidney health.

Details remain unconfirmed regarding specific events planned for World Kidney Day 2026, but the emphasis on awareness and prevention is clear. The global health community is urged to unite in addressing this growing health crisis.

The post World Kidney Day 2026: A Call to Action for Kidney Health appeared first on berightnews.

The Attack

However, the situation changed dramatically when Stryker experienced a global network disruption shortly after midnight on the US East Coast. The hacking group Handala claimed responsibility for the attack, asserting they had seized 50 terabytes of data from the corporation. This incident marks a significant escalation in cyber warfare, particularly targeting healthcare infrastructure.

Immediate Effects

The attack led to a complete outage of Stryker’s systems, prompting the company to confirm that they found no evidence of ransomware or malware. As a result, Stryker’s stock dropped by 4.5%, reflecting investor concerns about the implications of the breach.

Geopolitical Context

Experts suggest that the cyber attack is linked to escalating geopolitical tensions between Iran, Israel, and the United States, with Handala believed to have ties to the Iranian Ministry of Intelligence and Security. The attack is perceived as retaliation for recent US-Israeli strikes on Iran, which reportedly resulted in the deaths of 170 individuals.

Expert Perspectives

Sergey Shykevich, an expert in cybersecurity, emphasized the gravity of the situation, stating, “Critical healthcare infrastructure represents a high-value, high-impact target: disruption doesn’t just mean data loss, it can mean patient safety.” Dr. Jeff Tully echoed this sentiment, highlighting that healthcare networks and medical devices are integral to critical infrastructure.

The Stryker cyber attack not only disrupts a major healthcare provider but also raises alarms about the vulnerability of healthcare systems to cyber threats. As the situation develops, the implications for patient safety and data security will be closely monitored.

The post Stryker Cyber Attack: A Significant Escalation in Cyber Warfare appeared first on berightnews.